Monitoring vital signs in patients using long-term oxygen therapy
Official title: Impact of Remote Vital Signs Monitoring in People Using Long-term Oxygen Therapy : a Randomized Clinical Trial
Run by University of Sao Paulo General Hospital · NCT06882265 · Data updated 2026-11-12
This study tests if using a wearable device to monitor vital signs can improve the quality of life for adults with COPD and interstitial lung disease who are on long-term oxygen therapy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 85 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | University of Sao Paulo General Hospital Academic / other |
| Locations | 1 site (São Paulo, São Paulo) |
| Status | Recruiting |
| Started | November 10, 2024 |
| Main results expected | July 30, 2025 |
| Study ends | December 15, 2025 |
| Registry record updated | March 18, 2025 |
| Trial ID | NCT06882265 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults over 18 with stable COPD or ILD who are on optimized drug therapy and long-term oxygen therapy.
✕Probably not a fit
Patients with other significant lung diseases or severe heart conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the quality of life in adults with chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) who are on long-term oxygen therapy. Participants will be randomized into two groups: one receiving continuous monitoring through a wearable device for 90 days, and the other receiving a standard pulse oximeter. Both groups will have their vital signs monitored via a mobile application to assess the impact of remote monitoring on their health outcomes.
Why it matters
Potential benefit: If successful, this study could enhance the quality of life for patients on long-term oxygen therapy by providing better monitoring and management of their condition.
How similar studies have gone: Other studies have shown promise in using remote monitoring for chronic respiratory conditions, indicating potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with a clinical, radiological and/or anatomopathological diagnosis of COPD and ILD according to the 2020 ATS/JRS/ALAT guidelines; * Age over 18 years; * Clinical stability (absence of exacerbations or hospitalizations related to the underlying disease) for at least 6 weeks; * Patients who are on optimized drug therapy, including long-term home oxygen therapy (LTOT) * Have a smartphone compatible with the monitoring device; * Signing of the ICF to participate in the study. Exclusion Criteria: * Presence of other concomitant lung diseases; * Myocardial infarction within four months prior to the start of the study, unstable angina or severe heart disease (NYHA functional class III-IV) and/or decompensated. * Patients who received a lung transplant during the study * Living outside the coverage area or moving out of state
Where it's running
-
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP),
São Paulo, São Paulo, Brazil Recruiting
Study contacts
- Study coordinator: Celso RF Carval, Diretor do Estudo
- Email: cscarval@usp.br
- Phone: 55 11 98415-3234
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Shuttle Walking Test to predict breathing problems after lung surgery
This project will use a simple shuttle walking test before lung surgery to see if it predicts breathing problems and quality-of-life changes in people with chronic lung disease.
-
Using entropy to detect sleep breathing problems in chronic lung disease
This project will test whether entropy measurements from simple overnight oxygen and pulse recordings can find sleep-disordered breathing in adults with chronic lung conditions such as COPD, asthma, bronchiectasis, and interstitial lung disease.
-
Using the Lung Sliding Index to distinguish common lung diseases
This project will test whether the Lung Sliding Index (LSI) measured by bedside ultrasound can tell apart various lung conditions in adults with lung disease and in healthy volunteers.
-
Understanding muscle loss in patients with chronic lung diseases
This study looks at how muscle loss affects people with chronic lung diseases like COPD and ILD to see how common it is and how it relates to their overall health.
-
Evaluating dietary supplements and exercise for patients with sarcopenia and lung disease
This study is testing whether a combination of dietary supplements and supervised exercise can help people with sarcopenia and lung diseases like COPD and ILD improve their physical performance and lung function.
-
AERO-007: a inhaled LABA+LAMA combination for COPD through a nebulizer
This study tests whether a nebulized LABA+LAMA combination can improve lung function in adults with COPD.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.